Pharmacy Review: Reducing the Risks of Diabetes: The Pharmacist's Perspective

Abstract

Pharmacists are in a unique position to affect the lives of people living with diabetes. The pharmacist can identify people at risk, screen for pharmacotherapy problems, and give encouragement between physician visits. The medication knowledge that the clinical pharmacist brings to the health care team results in decreased costs, improved glycemic control, and greater adherence to ADA standards of care.

Keywords

diabetes pharmacists medication compliance

References

Ada. Clinical practice recommendations 2006. Diabetes Care. 2006;29(suppl): S43-S48.

Who. Diabetes Action Now . Geneva, Switzerland: WHO; 2004.

Cdc. National Diabetes Mellitus Fact Sheet. Atlanta, Ga: 2005.

Ada. Clinical practice recommendations 2003. Diabetes Care. 2003;26:917-932.

Cranor C.

Outcomes of Ashville Project. Pharm

Times. October 1998;(suppl):19-25.

Ada. Clinical practice recommendations 2007. Diabetes Care. 2007;30(suppl): S6-S12.

Kroon LA , Coleman LT , Koda-Kimble MA The management of type 2 diabetes mellitus: a call to action for pharmacists . US Pharm. May 1997; 22(suppl):1-18.

Coast-Senior EA , Kroner BA , Kelley CI , Trilli LE Management of type 2 diabetes patients by a pharmacist in primary clinics. Ann Pharmacother. 1998;32:636-641.

Jaber LA , Halapy H. , Fernet M. , Jummalapalli S. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother. 1996;30:238-243.

10.

Yanchick JK Implementation of a drug therapy monitoring clinic in a primary care setting. Am J Health Syst Pharm. 2000;57(suppl 4):S30-S34.

11.

Shane-McWhorter L , Fermo JD , Nanette NC , Bultemeier C. , Oderda GM National survey of pharmacist certified diabetes educators. Pharmacotherapy. 2002;22:1579-1593.